<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
  <title>GIDS Research Radar · Moldova</title>
  <link>https://globalinfectiousdisease.com/research/</link>
  <description>Published infectious-disease literature filtered to Moldova.</description>
  <language>en</language>
  <atom:link href="https://globalinfectiousdisease.com/research/rss/countries/md.xml" rel="self" type="application/rss+xml" />
  <lastBuildDate>Wed, 09 Sep 2026 07:02:01 GMT</lastBuildDate>
  <item>
    <title>Multistakeholder Consultations on Programmatic Progress, Challenges, and Policy Priorities for Lymphatic Filariasis Elimination in India</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-4269-ajtmh-26-0054-7a6f8f75/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-4269-ajtmh-26-0054-7a6f8f75/</guid>
    <pubDate>Thu, 27 Aug 2026 00:00:00 GMT</pubDate>
    <description>The synthesized recommendations supply practical frameworks for adjusting national control campaigns, optimizing funding deployment, and mitigating structural impediments that delay disease clearance objectives.</description>
    <category>Filariasis</category>
    <category>Health policy</category>
    <category>Surveillance</category>
    <category>Transmission dynamics</category>
    <category>Diagnostics</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Impact of COVID-19 on neglected tropical diseases in Zambia: a qualitative study of stakeholder perspectives</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1186-s40249-026-01491-0-094906d7/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1186-s40249-026-01491-0-094906d7/</guid>
    <pubDate>Tue, 25 Aug 2026 00:00:00 GMT</pubDate>
    <description>The results emphasize the importance of predictable domestic funding, robust monitoring systems, and sustainable local partnerships to maintain endemic disease control during systemic crises.</description>
    <category>COVID-19</category>
    <category>SARS</category>
    <category>One Health</category>
    <category>Treatment</category>
    <category>Surveillance</category>
    <category>Health policy</category>
    <category>Commentary</category>
  </item>
  <item>
    <title>Resistance evaluation and surveillance initiative for schistosomiasis treatment: study protocol for the RESIST project</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1186-s12879-025-12474-1-9272ef51/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1186-s12879-025-12474-1-9272ef51/</guid>
    <pubDate>Thu, 08 Jan 2026 00:00:00 GMT</pubDate>
    <description>The project is positioned as foundational work for population-based surveillance of praziquantel resistance in Schistosoma, with relevance to monitoring and mitigating persistent hotspots and to novel drugs in development.</description>
    <category>Schistosomiasis</category>
    <category>Surveillance</category>
    <category>Treatment</category>
    <category>Transmission dynamics</category>
    <category>Cross-sectional study</category>
  </item>
  <item>
    <title>Impact of seven years of mass drug administration and recrudescence of Schistosoma haematobium infections after one year of treatment gap in Zanzibar: Repeated cross-sectional studies</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0009127-5b4c1ee5/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0009127-5b4c1ee5/</guid>
    <pubDate>Fri, 12 Feb 2021 00:00:00 GMT</pubDate>
    <description>The study demonstrates that interruption of mass drug administration can lead to rapid recrudescence of urogenital schistosomiasis in hotspot areas. The authors recommend re-intensifying MDA plus additional interventions in hotspots and adapting strategies from mass administration to targeted surveillance-response in low-prevalence areas.</description>
    <category>Schistosomiasis</category>
    <category>Treatment</category>
    <category>Surveillance</category>
    <category>Transmission dynamics</category>
    <category>Cross-sectional study</category>
  </item>
  <item>
    <title>Factors affecting the uptake of preventive chemotherapy treatment for schistosomiasis in Sub-Saharan Africa: A systematic review</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0009017-b8a58681/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0009017-b8a58681/</guid>
    <pubDate>Tue, 19 Jan 2021 00:00:00 GMT</pubDate>
    <description>Schistosomiasis affects nearly 220 million people worldwide, primarily in Sub-Saharan Africa. Current guidelines recommend 75% treatment coverage among school-aged children, yet many programs fall short. High sustained coverage is essential given the risk of reinfection.</description>
    <category>Schistosomiasis</category>
    <category>Treatment</category>
    <category>Climate and environment</category>
    <category>Health policy</category>
    <category>Systematic review</category>
  </item>
</channel>
</rss>
